Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

OncoGenex Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

31 Jul 2015 Reuters Investment Profile 12 $20.00

ONCOGENEX PHARMACEUTICALS INC (OGXI) 12-months forecast

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

01 Aug 2015 Pechala's Reports 1 $15.00

ONCOGENEX PHARMACEUTICALS INC (OGXI) - REPORT FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

01 Aug 2015 Pechala's Reports 1 $25.00

Thomson Reuters Stock Report - OncoGenex Pharmaceuticals Inc (OGXI-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

31 Jul 2015 Thomson Reuters Stock Report 11 $25.00

OGXI: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

31 Jul 2015 New Constructs, LLC 10 $25.00

Value Graph: ONCOGENEX PHARM -- OGXI

31 Jul 2015 Ford Investor Services, Inc. 1 $12.00

ValuEngine Industry Report for Medical-Drugs(OGXI)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

30 Jul 2015 ValuEngine, Inc. 10 $49.00

ValuEngine Rating and Forecast Report for OGXI

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

27 Jul 2015 ValuEngine, Inc. 10 $25.00

Wright Investors Service Comprehensive Report for Oncogenex Pharmaceuticals, Incorporation

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

27 Jul 2015 Wright Reports 56 $75.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ONCOGENEX PHARMACEUTICALS including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

24 Jul 2015 Jefferson Research 11 $20.00